| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 30,2 M € | +10.3% | 27,3 M € | +5.9% | 25,8 M € | +12.9% | 22,9 M € | -6.6% | 24,5 M € | -36.7% | 38,6 M € | +23.4% | 31,3 M € | +77.3% | 17,7 M € | +9.9% | 16,1 M € | +24.4% | 12,9 M € | -10.3% | 14,4 M € | -0.7% | 14,5 M € | -0.2% | 14,5 M € | +7.6% | 13,5 M € | +1.9% | 13,3 M € | +2.6% | 12,9 M € | -2.9% | 13,3 M € | -0.9% | 13,4 M € | -9.1% | 14,8 M € | +10.7% | 13,4 M € | |
| EBITDA | 2,4 M € | +115.7% | 1,1 M € | -29.6% | 1,6 M € | -8.4% | 1,7 M € | +56.4% | 1,1 M € | +14.3% | 974,4 k € | +155.7% | 381,1 k € | -71.4% | 1,3 M € | +51.6% | 879,3 k € | +114.2% | 410,5 k € | +32.5% | 309,8 k € | -74.5% | 1,2 M € | -24.5% | 1,6 M € | +15.9% | 1,4 M € | +23.5% | 1,1 M € | -23.8% | 1,5 M € | +17.8% | 1,3 M € | -4.3% | 1,3 M € | -46.7% | 2,5 M € | +10.4% | 2,2 M € | |
| Operating profit | 1,6 M € | +15.6% | 1,4 M € | -1.4% | 1,4 M € | +138.3% | 585,7 k € | -50.8% | 1,2 M € | +36.7% | 871,5 k € | -16.6% | 1,0 M € | +23.9% | 843,1 k € | +121.8% | 380,1 k € | +32.6% | 286,6 k € | +840.5% | -38,7 k € | -102.5% | 1,5 M € | +11.1% | 1,4 M € | +31.6% | 1,0 M € | +27.1% | 821,4 k € | -14.3% | 958,2 k € | +0.1% | 957,2 k € | -1.1% | 968,0 k € | -51.7% | 2,0 M € | +15.7% | 1,7 M € | |
| Profit/loss | 1,1 M € | +13.2% | 988,9 k € | +6.0% | 932,9 k € | +770.8% | 107,1 k € | -86.2% | 774,3 k € | +125.1% | 344,0 k € | +7.1% | 321,1 k € | -40.6% | 540,2 k € | +163.9% | 204,7 k € | +77.7% | 115,2 k € | +461.8% | -31,9 k € | -102.8% | 1,1 M € | +9.1% | 1,0 M € | +19.8% | 856,7 k € | +17.3% | 730,3 k € | -7.1% | 785,8 k € | +0.1% | 784,7 k € | -9.3% | 865,4 k € | -41.3% | 1,5 M € | +20.1% | 1,2 M € | |
| Equity | 9,7 M € | -41.9% | 16,7 M € | +6.3% | 15,7 M € | -16.1% | 18,7 M € | +0.6% | 18,6 M € | +4.3% | 17,8 M € | +2.0% | 17,5 M € | +3.6% | 16,9 M € | +3.3% | 16,3 M € | +1.3% | 16,1 M € | +0.7% | 16,0 M € | -0.2% | 16,0 M € | +7.5% | 14,9 M € | +7.4% | 13,9 M € | +6.6% | 13,0 M € | +5.9% | 12,3 M € | +6.8% | 11,5 M € | +7.3% | 10,7 M € | +8.8% | 9,9 M € | +17.6% | 8,4 M € | |
| Total assets | 20,1 M € | -11.4% | 22,7 M € | +6.0% | 21,4 M € | -5.9% | 22,8 M € | -0.2% | 22,8 M € | -22.1% | 29,3 M € | +5.4% | 27,8 M € | +35.0% | 20,6 M € | +0.4% | 20,5 M € | -0.7% | 20,6 M € | +2.2% | 20,2 M € | -5.9% | 21,5 M € | +8.1% | 19,9 M € | +9.2% | 18,2 M € | +0.3% | 18,1 M € | +10.9% | 16,3 M € | +2.5% | 15,9 M € | +9.4% | 14,6 M € | +19.4% | 12,2 M € | +14.8% | 10,6 M € | |
| Cash | 1,5 M € | -24.6% | 2,0 M € | +27.4% | 1,5 M € | -67.6% | 4,7 M € | -18.6% | 5,8 M € | +92.7% | 3,0 M € | +120.7% | 1,4 M € | -86.4% | 10,1 M € | +1264.4% | 738,1 k € | -46.8% | 1,4 M € | -14.3% | 1,6 M € | -65.1% | 4,6 M € | +20.9% | 3,8 M € | +74.7% | 2,2 M € | -57.0% | 5,1 M € | +14.5% | 4,5 M € | +1.3% | 4,4 M € | -47.0% | 8,3 M € | +76.8% | 4,7 M € | +76.6% | 2,7 M € | |
| Debts | 9,3 M € | +67.2% | 5,6 M € | +15.0% | 4,8 M € | +92.3% | 2,5 M € | -14.9% | 3,0 M € | -66.9% | 8,9 M € | +29.1% | 6,9 M € | +172.1% | 2,5 M € | -1.1% | 2,6 M € | +1.1% | 2,5 M € | +38.5% | 1,8 M € | -58.9% | 4,5 M € | +13.5% | 3,9 M € | +12.7% | 3,5 M € | -16.4% | 4,2 M € | +27.4% | 3,3 M € | -11.5% | 3,7 M € | +15.6% | 3,2 M € | +116.0% | 1,5 M € | -14.2% | 1,7 M € | |
| Staff | 71,4 | 73,6 | 71 | 69 | 69,7 | 74,2 | 50,6 | 41 | 37,7 | 33,2 | 32,8 | 30,5 | 29,3 | 28,9 | 27,6 | 26,9 | 27,3 | 27,3 | 26,6 | 25,9 | ||||||||||||||||||||
Public limited company · Dilbeek · incorporated on 25/08/1976 · 71,4 ETP
Public limited company profitable and well capitalised. Cash position declining (-24.6%).
Solid counterparty for a standard engagement.
GETINGE BELGIUM is a Public limited company incorporated in 1976. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Dilbeek. It employs on average 71,4 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette